Q3 Korean Biotech Roundup: Eyes On Orum's IPO Plan

HLB Resubmits HCC Combo In US

 
• By Jung Won Shin
  
IPO
Orum Says Market Conditions Turn More Favorable For An IPO • Source: Shutterstock

More from South Korea

More from Focus On Asia